Literature DB >> 33877880

The radiologic (CT/MRI)-pathological correlations of the salivary duct carcinoma (SDC) with hyaline degeneration and peripheral nerve invasion.

Nobukata Kazawa1, Yuta Shibamoto1, Yasujirou Hirose1, Yoriko Yamashita2.   

Abstract

OBJECTIVES: Salivary duct carcinoma is an aggressive tumour commonly showing local invasion and/or nerve palsy. However, their CT/MRI findings, especially, regarding T2WI, and the diffusion-weighted-image (DWI), were not well known. In this study, we correlated the CT/MRI appearance and the pathological findings containing the nerve invasion cases such as a facial nerve.
METHODS: We reviewed 14 cases of SDC (parotid = 11, submandibular = 2, minor salivary gland = 1) pathologically proven peripheral nerve involvement. Their CT findings of all patient including dynamic contrast-enhancement study、MRI (n = 9) and DWI (n = 6) were also analyzed with histopathological correlation.
RESULTS: On contrast-enhanced CT, the solid component was moderately enhanced. On MRI, T2WI central low signal core (n = 6) with peripheral high intensity rim (n = 5) was frequently observed except heterogeneous low and high (n = 1), diffuse low (n = 1), and high (n = 1) signal cases. The hyaline degenerative area located in the tumour core was poorly enhanced. Eleven tumours had an ill-defined margin, reflecting invasive tumour growth. On DWI, they showed high signal [the central low and peripherally high (n = 4), and diffuse (n = 1), heterogeneously high signal (n = 1)]. The mean ADC value was 1.148 ~ 0.961 x 10-3 mm2/s. With pathological correlation, the central low signal area on T2WI reflected hyaline degeneration. The sites of gross nerve involvement were revealed as tubular or branching structures on CE-CT (n = 3), and MRI (n = 1).
CONCLUSIONS: (1) We frequently observed a central low signal area on T2WI/DWI in SDC. With histopathological correlation, it corresponded to the central hyaline degeneration with the peripheral viable tumour. 2) The gross nerve involvement might be detected as a strongly enhancement structure.

Entities:  

Keywords:  Facial nerve; Hyaline; Salivary gland neoplasms

Mesh:

Year:  2021        PMID: 33877880      PMCID: PMC8474137          DOI: 10.1259/dmfr.20200603

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   3.525


  37 in total

1.  Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients.

Authors:  Young Cheol Weon; Sun-Won Park; Hyung-Jin Kim; Han-Sin Jeong; Young-Hyeh Ko; In Suh Park; Sung Tae Kim; Chung Hwan Baek; Young-Ik Son
Journal:  Neuroradiology       Date:  2012-02-04       Impact factor: 2.804

2.  Salivary duct carcinoma with perineural spread to facial canal: F-18 FDG PET/CT detection.

Authors:  Ba D Nguyen; Michael C Roarke
Journal:  Clin Nucl Med       Date:  2008-12       Impact factor: 7.794

3.  Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors.

Authors:  Ahmed Abdel Khalek Abdel Razek
Journal:  Magn Reson Imaging       Date:  2019-08-15       Impact factor: 2.546

4.  Multiphase contrast-enhanced computed tomography imaging features of salivary duct carcinoma: differentiation from other salivary gland malignancies.

Authors:  Wen-Li Wu; Cheng-Long Wang; Dan Li; Jin Luo; Jun-Yong Ye; Sheng-Sheng Xu
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2019-06-06

5.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.

Authors:  Raja R Seethala; Göran Stenman
Journal:  Head Neck Pathol       Date:  2017-02-28

6.  Dynamic contrast-enhanced MRI for differentiation of major salivary glands neoplasms, a 3-T MRI study.

Authors:  L Aghaghazvini; F Salahshour; N Yazdani; H Sharifian; S Kooraki; M Pakravan; M Shakiba
Journal:  Dentomaxillofac Radiol       Date:  2014-10-09       Impact factor: 2.419

7.  Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature.

Authors:  Toshitaka Nagao; Thomas A Gaffey; Hiromi Serizawa; Keiichi Iwaya; Akinori Watanabe; Tomoyuki Yoshida; Kazuto Yamazaki; Masato Sageshima; Jean E Lewis
Journal:  Am J Clin Pathol       Date:  2004-08       Impact factor: 2.493

8.  Imaging of perineural tumor spread from palatal carcinoma.

Authors:  L E Ginsberg; F DeMonte
Journal:  AJNR Am J Neuroradiol       Date:  1998-09       Impact factor: 3.825

9.  Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.

Authors:  Hidetake Yabuuchi; Tatsuro Fukuya; Tsuyoshi Tajima; Yoichi Hachitanda; Kichinobu Tomita; Mitsuru Koga
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

10.  Salivary duct carcinoma of the parotid gland: clinical and MR features in six patients.

Authors:  N Kashiwagi; S Takashima; Y Tomita; Y Araki; K Yoshino; S Taniguchi; K Nakanishi
Journal:  Br J Radiol       Date:  2009-03-30       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.